Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
Abstract
BACKGROUND: bacteremia is unclear. METHODS: bacteremia. The primary outcome, which was evaluated with a hierarchical Bayesian logistic-regression model, was death from any cause within 90 days after enrollment in the platform. We assessed the posterior probability of the noninferiority of cefazolin to flucloxacillin or cloxacillin (with the criterion for noninferiority prespecified as an adjusted odds ratio of
Fields of Study & Subjects
Antimicrobial Resistance in Staphylococcus
Antibiotics Pharmacokinetics and Efficacy
Ocular Infections and Treatments
Publication details
- Journal / source
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Volume
- 394
- Issue
- 23
- Pages
- 2329–2339
- Publication date
- 17 June 2026
- Language
- EN